Last reviewed · How we verify
Low pressure hyperbaric oxygen therapy — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Low pressure hyperbaric oxygen therapy (Low pressure hyperbaric oxygen therapy) — Paul G. Harch, M.D..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Low pressure hyperbaric oxygen therapy TARGET | Low pressure hyperbaric oxygen therapy | Paul G. Harch, M.D. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Low pressure hyperbaric oxygen therapy CI watch — RSS
- Low pressure hyperbaric oxygen therapy CI watch — Atom
- Low pressure hyperbaric oxygen therapy CI watch — JSON
- Low pressure hyperbaric oxygen therapy alone — RSS
Cite this brief
Drug Landscape (2026). Low pressure hyperbaric oxygen therapy — Competitive Intelligence Brief. https://druglandscape.com/ci/low-pressure-hyperbaric-oxygen-therapy. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing